Search research articles
Contact Us
Filters
Showing results (1-10 of 71) with videos related to
Page
of 8
Sort By:
Blood
|
July 24, 2010
Proteasome and HDAC: who's zooming who?
David McConkey
European Urology
|
November 28, 2017
Reply to Joshua A. Linscott, Angela B. Smith, and Jesse D. Sammon's Letter to the Editor re: Woonyoung Choi, Andrea Ochoa, David J. McConkey, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Eur Urol 2017;72:354-65
Woonyoung Choi, David McConkey
Annual Review of Pathology
|
February 25, 2016
Origins of Bladder Cancer
Bogdan Czerniak, Colin Dinney, David McConkey
European Urology Oncology
|
August 7, 2019
Does it matter whether a T1 high-grade tumor is molecularly classified?
Arnulf Stenzl, David McConkey, Joaquim Bellmunt
European Urology
|
September 10, 2014
Reply to Mattias Aine, Fredrik Liedberg, Gottfrid Sjödahl, and Mattias Höglund's Letter to the Editor re: David J. McConkey, Woonyoung Choi, Colin P.N. Dinney. New insights into subtypes of invasive bladder cancer: considerations of the clinician. Eur Urol 2014;66:609-10
David McConkey, Woonyoung Choi, Colin Dinney
Cancer Biology & Therapy
|
May 24, 2005
Velcade displays promising activity in primary effusion lymphoma cells
David McConkey, Steffan T Nawrocki, Robert Andtbacka
Bladder Cancer (Amsterdam, Netherlands)
|
July 12, 2024
What is a Bladder Cancer Molecular Subtype? - Counterpoint
François Radvanyi, Francisco X Real, David McConkey
European Urology Oncology
|
August 10, 2019
Does Variant Histology Change Management of Non-muscle-invasive Bladder Cancer?
Maximilian Burger, Ashish M Kamat, David McConkey
Bladder Cancer (Amsterdam, Netherlands)
|
August 12, 2024
The Evolution of Nadofaragene Firadenovec: A Review and the Path Forward
Alexis R Steinmetz, Sharada Mokkapati, David McConkey, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 8, 2020
Renal Cell and Urothelial Carcinoma: Biomarkers for New Treatments
Andrew L Schmidt, Arlene Siefker-Radtke, David McConkey, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 71) with videos related to
Sort By:
Page
of 8
Blood
|
July 24, 2010
Proteasome and HDAC: who's zooming who?
David McConkey
European Urology
|
November 28, 2017
Reply to Joshua A. Linscott, Angela B. Smith, and Jesse D. Sammon's Letter to the Editor re: Woonyoung Choi, Andrea Ochoa, David J. McConkey, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Eur Urol 2017;72:354-65
Woonyoung Choi, David McConkey
Annual Review of Pathology
|
February 25, 2016
Origins of Bladder Cancer
Bogdan Czerniak, Colin Dinney, David McConkey
European Urology Oncology
|
August 7, 2019
Does it matter whether a T1 high-grade tumor is molecularly classified?
Arnulf Stenzl, David McConkey, Joaquim Bellmunt
European Urology
|
September 10, 2014
Reply to Mattias Aine, Fredrik Liedberg, Gottfrid Sjödahl, and Mattias Höglund's Letter to the Editor re: David J. McConkey, Woonyoung Choi, Colin P.N. Dinney. New insights into subtypes of invasive bladder cancer: considerations of the clinician. Eur Urol 2014;66:609-10
David McConkey, Woonyoung Choi, Colin Dinney
Cancer Biology & Therapy
|
May 24, 2005
Velcade displays promising activity in primary effusion lymphoma cells
David McConkey, Steffan T Nawrocki, Robert Andtbacka
Bladder Cancer (Amsterdam, Netherlands)
|
July 12, 2024
What is a Bladder Cancer Molecular Subtype? - Counterpoint
François Radvanyi, Francisco X Real, David McConkey
European Urology Oncology
|
August 10, 2019
Does Variant Histology Change Management of Non-muscle-invasive Bladder Cancer?
Maximilian Burger, Ashish M Kamat, David McConkey
Bladder Cancer (Amsterdam, Netherlands)
|
August 12, 2024
The Evolution of Nadofaragene Firadenovec: A Review and the Path Forward
Alexis R Steinmetz, Sharada Mokkapati, David McConkey, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 8, 2020
Renal Cell and Urothelial Carcinoma: Biomarkers for New Treatments
Andrew L Schmidt, Arlene Siefker-Radtke, David McConkey, et al.
Page
of 8